Vericel (VCEL)
(Delayed Data from NSDQ)
$46.05 USD
+0.60 (1.32%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $45.48 -0.57 (-1.24%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum D VGM
Price, Consensus and EPS Surprise
VCEL 46.05 +0.60(1.32%)
Will VCEL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for VCEL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VCEL
Vericel Corporation (VCEL) Q4 Earnings Beat Estimates
Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates
VCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You Looking for a Top Momentum Pick? Why Vericel Corporation (VCEL) is a Great Choice
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q4 Earnings Expected to Decline
Vericel Corporation (VCEL) to Report Q4 Results: Wall Street Expects Earnings Growth
Other News for VCEL
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
Vericel price target raised by $3 at BTIG, here's why
Commit To Buy Vericel At $25, Earn 9% Annualized Using Options
Director ZERBE ROBERT L MD Sells Shares of Vericel Corp (VCEL)
Vericel Reaches Analyst Target Price